Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 9461402, 7 pages
https://doi.org/10.1155/2017/9461402
Research Article

Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy

1Sbarro Health Research Organization, Temple University, Philadelphia, PA, USA
2Unit of Radiation Oncology, University Hospital of Siena, Siena, Italy
3Department of Medicine, Surgery and Neurological Sciences, University of Siena, Siena, Italy
4Unit of Pathological Anatomy, Department of Medicine, Surgery and Neurological Sciences, University of Siena, Siena, Italy
5Unit of Neuroradiology, University Hospital of Siena, Siena, Italy

Correspondence should be addressed to Paolo Tini; ti.orebil@init-oloap

Received 6 June 2017; Accepted 9 August 2017; Published 12 October 2017

Academic Editor: Nader Pouratian

Copyright © 2017 Paolo Tini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Paolo Tini, Valerio Nardone, Pierpaolo Pastina, et al., “Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy,” BioMed Research International, vol. 2017, Article ID 9461402, 7 pages, 2017. doi:10.1155/2017/9461402